Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions

被引:148
|
作者
Perez, Lorena [1 ,2 ,3 ]
Munoz-Durango, Natalia [3 ]
Riedel, Claudia A. [1 ,2 ,3 ]
Echeverria, Cesar [4 ]
Kalergis, Alexis M. [3 ,5 ,6 ]
Cabello-Verrugio, Claudio [1 ,2 ,3 ]
Simon, Felipe [1 ,2 ,3 ]
机构
[1] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Ave Republ 239, Santiago 8370134, Chile
[2] Univ Andres Bello, Fac Med, Ave Republ 239, Santiago 8370134, Chile
[3] Millennium Inst Immunol & Immunotherapy, Ave Alameda 340, Santiago 8331150, Chile
[4] Univ Bernardo O Higgins, Lab Bionanotecnol, Gen Gana 1780, Santiago 8370854, Chile
[5] Pontificia Univ Catolica Chile, Fac Med, Dept Reumatol, Ave Alameda 340, Santiago 8331150, Chile
[6] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Ave Alameda 340, Santiago 8331150, Chile
关键词
TGF-beta; TNE-alpha; Endothelium; Fibrosis; Interleukin; Inflammation; NF-KAPPA-B; TGF-BETA; CARDIAC FIBROSIS; PROGENITOR CELLS; TRANSFORMING GROWTH-FACTOR-BETA-2; PULMONARY-HYPERTENSION; RENAL FIBROSIS; POTENTIAL ROLE; IN-VITRO; PROMOTES;
D O I
10.1016/j.cytogfr.2016.09.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
During the last decade, the endothelial-to-mesenchymal transition (EndMT) process has attracted considerable attention due to associations with the onset of certain diseases, such as organ fibrosis and cancer. Several studies have assessed the mechanisms and signaling pathways that regulate endothelial fibrosis in the context of human pathologies. A number of inflammatory mediators, including pro inflammatory cytokines, growth factors, oxidative stress, and toxins, induce the conversion of endothelial cells into mesenchymal fibroblast-like cells that promote disease progression. This review is separated into five chapters that critically present current knowledge on EndMT in the context of pathology. First, the main characteristics of EndMT are summarized, with a focus on the endothelial protein pattern changes that modulate the expressions of endothelial/fibrotic markers and extracellular matrix proteins. These expressions could serve as mechanisms for explaining potential EndMT contributions to human pathologies in adults. Second, the main findings supporting a connection between EndMT-mediated endothelial fibrosis and inflammatory conditions are presented. These connections could be linked to the onset and progression of pathological conditions. Third, EndMT inducers are described in detail. This includes considerations on the actions of the first and most well-known EndMT inducer, TGF-beta; of the most prominent pro-inflammatory cytokines released during inflammation, such as IL 1-beta and TNF-alpha; and of the NF-kappa B transcription factor, a common player during inflammation-induced EndMT. Furthermore, thorough attention is given to EndMT induction by endotoxins in the context of bacterial infectious diseases. Additionally, the participation of the inflammatory oxidative stress environment in the EndMT induction was also reviewed. Fourth, the pathophysiological findings of inflammation induced EndMT are presented, and, fifth, special focus is placed on associations with cancer onset and development. Altogether, this review highlights the important role of EndMT-mediated endothelial fibrosis during inflammation in human pathologies. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:41 / 54
页数:14
相关论文
共 50 条
  • [21] Endothelial-to-Mesenchymal Transition in Pulmonary Hypertension
    Ranchoux, Benoit
    Antigny, Fabrice
    Rucker-Martin, Catherine
    Hautefort, Aurelie
    Pechoux, Christine
    Bogaard, Harm Jan
    Dorfmueller, Peter
    Remy, Severine
    Lecerf, Florence
    Plante, Sylvie
    Chat, Sophie
    Fadel, Elie
    Houssaini, Amal
    Anegon, Ignacio
    Adnot, Serge
    Simonneau, Gerald
    Humbert, Marc
    Cohen-Kaminsky, Sylvia
    Perros, Frederic
    CIRCULATION, 2015, 131 (11) : 1006 - +
  • [22] Endothelial CD38-induced endothelial-to-mesenchymal transition is a pivotal driver in pulmonary fibrosis
    Hu, Min
    Guan, Xiao-Hui
    Wang, Ling-Fang
    Xu, Hao-Min
    Ke, Shu-Fen
    Yuan, Qing-Yun
    Tan, Hui-Lan
    Wu, Jie
    Yu, Guan-Hui
    Huang, Qi-Ming
    Liu, Yu
    Hu, Long
    Deng, Ke-Yu
    Xin, Hong-Bo
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2024, 82 (01)
  • [23] Endothelial-to-mesenchymal Transition in Cardiovascular Pathology
    Simons, Michael
    FASEB JOURNAL, 2015, 29
  • [24] Endothelial-to-mesenchymal transition in systemic sclerosis
    Di Benedetto, P.
    Ruscitti, P.
    Berardicurti, O.
    Vomero, M.
    Navarini, L.
    Dolo, V.
    Cipriani, P.
    Giacomelli, R.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2021, 205 (01): : 12 - 27
  • [25] Acetate controls endothelial-to-mesenchymal transition
    Zhu, Xiaolong
    Wang, Yunyun
    Soaita, Ioana
    Lee, Heon-Woo
    Bae, Hosung
    Boutagy, Nabil
    Bostwick, Anna
    Zhang, Rong-Mo
    Bowman, Caitlyn
    Xu, Yanying
    Trefely, Sophie
    Chen, Yu
    Qin, Lingfeng
    Sessa, William
    Tellides, George
    Jang, Cholsoon
    Snyder, Nathaniel W.
    Yu, Luyang
    Arany, Zoltan
    Simons, Michael
    CELL METABOLISM, 2023, 35 (07) : 1163 - 1178.e10
  • [26] Role of the endothelial-to-mesenchymal transition in renal fibrosis of chronic kidney disease
    Jianhua He
    Yong Xu
    Daisuke Koya
    Keizo Kanasaki
    Clinical and Experimental Nephrology, 2013, 17 : 488 - 497
  • [27] Foramen Ovale Closure Is a Process of Endothelial-to-Mesenchymal Transition Leading to Fibrosis
    Elliott, Graeme C.
    Gurtu, Rockesh
    McCollum, Charles
    Newman, William G.
    Wang, Tao
    PLOS ONE, 2014, 9 (09):
  • [28] Inhibition of endothelial-to-mesenchymal transition reduces myocardial fibrosis in heart failure
    Graber, M.
    Fiegl, M.
    Stranger, L.
    Hirsch, J.
    Naegele, F.
    Poelzl, L.
    Engler, C.
    Mair, S.
    Grimm, M.
    Cooke, J. P.
    Gollmann-Tepekoeylue, C.
    Holfeld, J.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S397 - S398
  • [29] Endothelial Proliferation Precedes the Development of Endothelial-To-Mesenchymal Transition (EndMT).
    Woda, C.
    Bruneau, S.
    Briscoe, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 384 - 384
  • [30] Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy
    Zhang, Lu
    He, Jiaqi
    Wang, Junyan
    Liu, Jing
    Chen, Zixin
    Deng, Bo
    Wei, Lan
    Wu, Hanqin
    Liang, Birong
    Li, Huan
    Huang, Yusheng
    Lu, Lu
    Yang, Zhongqi
    Xian, Shaoxiang
    Wang, Lingjun
    CELL DEATH & DISEASE, 2021, 12 (05)